INTRODUCTION: Multisystem inflammatory syndrome in children (MIS-C) is a new clinical entity that has emerged in the context of the COVID-19 pandemic. Despite the less severe course of the disease, varying degrees of cardiovascular events may occur in MIS-C; however, data on vascular changes occurring in MIS-C are still lacking. Endothelial dysfunction (ED) is thought to be one of the key risk factors contributing to MIS-C. BACKGROUND: We conducted a prospective observational study. We investigated possible manifestations of cardiac and endothelial involvement in MIS-C after the treatment of the acute stage and potential predictive biomarkers in patients with MIS-C. METHODS: Twenty-seven consecutive pediatric subjects (≥9 years), at least three months post-treated MIS-C of varying severity, in a stable condition, and twenty-three age- and sex-matched healthy individuals (HI), were enrolled. A combined non-invasive diagnostic approach was used to assess endothelial function as well as markers of organ damage using cardiac examination and measurement of the reactive hyperemia index (RHI), by recording the post- to pre-occlusion pulsatile volume changes and biomarkers related to ED and cardiac disease. RESULTS: MIS-C patients exhibited a significantly lower RHI (indicative of more severe ED) than those in HI (1.32 vs. 1.80; p = 0.001). The cutoff of RHI ≤ 1.4 was independently associated with a higher cardiovascular risk. Age and biomarkers significantly correlated with RHI, while serum cystatin C (Cys C) levels were independently associated with a diminished RHI, suggesting Cys C as a surrogate marker of ED in MIS-C. CONCLUSIONS: Patients after MIS-C display evidence of ED, as shown by a diminished RHI and altered endothelial biomarkers. Cys C was identified as an independent indicator for the development of cardiovascular disease. The combination of these factors has the potential to better predict the cardiovascular consequences of MIS-C. Our study suggests that ED may be implicated in the pathophysiology of this disease.

Department of Clinical Biochemistry and Hematology Faculty Hospital Faculty of Medicine in Pilsen Charles University Prague Alej Svobody 80 30460 Pilsen Czech Republic

Department of Pediatrics Faculty Hospital Faculty of Medicine and Dentistry Palacky University in Olomouc 1 P Pavlova 185 6 77520 Olomouc Czech Republic

Department of Pediatrics Faculty Hospital Faculty of Medicine in Pilsen Charles University Prague Alej Svobody 80 30460 Pilsen Czech Republic

Department of Pediatrics Faculty Hospital Faculty of Medicine Ostrava University 17 Listopadu 1790 70852 Ostrava Czech Republic

Zobrazit více v PubMed

Otifi H.M., Adiga B.K. Endothelial Dysfunction in COVID-19 Infection. Am. J. Med. Sci. 2022;363:281–287. doi: 10.1016/j.amjms.2021.12.010. PubMed DOI PMC

Hughes S. COVID-19 Cardiovascular Complications in Children: AHA Statement. [(accessed on 12 April 2022)]. Available online: https://www.medscape.com/viewarticle/972062?reg=1#vp_2.

Patel J.M. Multisystem Inflammatory Syndrome in Children (MIS-C) Curr. Allergy Asthma Rep. 2022;22:53–60. doi: 10.1007/s11882-022-01031-4. PubMed DOI PMC

Evans P.C., Rainger G.E., Mason J.C., Guzik T.J., Osto E., Stamataki Z., Neil D., Hoefer I.E., Fragiadaki M., Waltenberger J., et al. Endothelial Dysfunction in COVID-19: A Position Paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc. Res. 2020;116:2177–2184. doi: 10.1093/cvr/cvaa230. PubMed DOI PMC

Wu E.Y., Campbell M.J. Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19. Curr. Cardiol. Rep. 2021;23:168. doi: 10.1007/s11886-021-01602-3. PubMed DOI PMC

Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arter. Thromb. Vasc. Biol. 2003;23:168–175. doi: 10.1161/01.ATV.0000051384.43104.FC. PubMed DOI

Morrison K.M., Dyal L., Conner W., Helden E., Newkirk L., Yusuf S., Lonn E. Cardiovascular Risk Factors and Non-Invasive Assessment of Subclinical Atherosclerosis in Youth. Atherosclerosis. 2010;208:501–505. doi: 10.1016/j.atherosclerosis.2009.07.034. PubMed DOI

Hamburg N.M., Keyes M.J., Larson M.G., Vasan R.S., Schnabel R., Pryde M.M., Mitchell G.F., Sheffy J., Vita J.A., Benjamin E.J. Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study. Circulation. 2008;117:2467–2474. doi: 10.1161/CIRCULATIONAHA.107.748574. PubMed DOI PMC

Bökenkamp A., Herget-Rosenthal S., Bökenkamp R. Cystatin C, kidney function and cardiovascular disease. Pediatr. Nephrol. 2006;21:1223. doi: 10.1007/s00467-006-0192-5. Erratum in Pediatr. Nephrol. 2007, 22, 475. PubMed DOI

Rodriguez-Gonzalez M., Castellano-Martinez A., Cascales-Poyatos H.M., Perez-Reviriego A.A. Cardiovascular Impact of COVID-19 with a Focus on Children: A Systematic Review. World J. Clin. Cases. 2020;8:5250–5283. doi: 10.12998/wjcc.v8.i21.5250. PubMed DOI PMC

Gavriilaki E., Anyfanti P., Gavriilaki M., Lazaridis A., Douma S., Gkaliagkousi E. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Curr. Hypertens. Rep. 2020;22:63. doi: 10.1007/s11906-020-01078-6. PubMed DOI PMC

Widlansky M.E., Gokce N., Keaney J.F., Jr., Vita J.A. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol. 2003;42:1149–1160. doi: 10.1016/S0735-1097(03)00994-X. PubMed DOI

Ramcharan T., Nolan O., Lai C.Y., Prabhu N., Krishnamurthy R., Richter A.G., Jyothish D., Kanthimathinathan H.K., Welch S.B., Hackett S., et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatr. Cardiol. 2020;41:1391–1401. doi: 10.1007/s00246-020-02391-2. PubMed DOI PMC

Kaushik A., Gupta S., Sood M., Sharma S., Verma S. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection. Pediatr. Infect. Dis. J. 2020;39:e340–e346. doi: 10.1097/INF.0000000000002888. PubMed DOI

Esposito S., Marchetti F., Lanari M., Caramelli F., De Fanti A., Vergine G., Iughetti L., Fornaro M., Suppiej A., Zona S., et al. COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE-CO-Ped), Italy. Int. J. Environ. Res. Public Health. 2021;18:3919. doi: 10.3390/ijerph18083919. PubMed DOI PMC

Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., et al. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography. J. Am. Soc. Echocardiogr. 1989;2:358–367. doi: 10.1016/S0894-7317(89)80014-8. PubMed DOI

Lopez L., Colan S., Stylianou M., Granger S., Trachtenberg F., Frommelt P., Pearson G., Camarda J., Cnota J., Cohen M., et al. Relationship of Echocardiographic Z Scores Adjusted for Body Surface Area to Age, Sex, Race, and Ethnicity. Circ. Cardiovasc. Imaging. 2017;10:e006979. doi: 10.1161/CIRCIMAGING.117.006979. PubMed DOI PMC

Kreslová M., Kirchnerová O., Rajdl D., Sudová V., Blažek J., Sýkorová A., Jehlička P., Trefil L., Schwarz J., Pomahačová R., et al. Bronchial Asthma as a Cardiovascular Risk Factor: A Prospective Observational Study. Biomedicines. 2022;10:2614. doi: 10.3390/biomedicines10102614. PubMed DOI PMC

Hamburg N.M., Palmisano J., Larson M.G., Sullivan L.M., Lehman B.T., Vasan R.S., Levy D., Mitchell G.F., Vita J.A., Benjamin E.J. Relation of Brachial and Digital Measures of Vascular Function in the Community. Hypertension. 2011;57:390–396. doi: 10.1161/HYPERTENSIONAHA.110.160812. PubMed DOI PMC

Güllü U.U., İpek S., Güngör Ş., Yurttutan S., Demiray Ş. Haematological Parameters Predicting Cardiac Involvement in Children with COVID-19 Infection. J. Paediatr. Child Health. 2022 doi: 10.1111/jpc.16203. PubMed DOI PMC

Pottel H., Delanaye P., Schaeffner E., Dubourg L., Eriksen B.O., Melsom T., Lamb E.J., Rule A.D., Turner S.T., Glassock R.J., et al. Estimating Glomerular Filtration Rate for the Full Age Spectrum from Serum Creatinine and Cystatin C. Nephrol. Dial. Transplant. 2017;32:497–507. doi: 10.1093/ndt/gfw425. PubMed DOI PMC

Benoit S.W., Ciccia E.A., Devarajan P. Cystatin C as a Biomarker of Chronic Kidney Disease: Latest Developments. Expert Rev. Mol. Diagn. 2020;20:1019–1026. doi: 10.1080/14737159.2020.1768849. PubMed DOI PMC

Srisawat N., Kellum J.A. The Role of Biomarkers in Acute Kidney Injury. Crit. Care Clin. 2020;36:125–140. doi: 10.1016/j.ccc.2019.08.010. PubMed DOI

Ix J.H., Shlipak M.G., Chertow G.M., Whooley M.A. Association of Cystatin C with Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons with Coronary Heart Disease. Circulation. 2007;115:173–179. doi: 10.1161/CIRCULATIONAHA.106.644286. PubMed DOI PMC

Shlipak M.G., Katz R., Sarnak M.J., Fried L.F., Newman A.B., Stehman-Breen C., Seliger S.L., Kestenbaum B., Psaty B., Tracy R.P., et al. Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease. Ann. Intern. Med. 2006;145:237–246. doi: 10.7326/0003-4819-145-4-200608150-00003. PubMed DOI

Fabjan T.H., Penko M., Hojs R. Newer Glomerular Filtration Rate Estimating Equations for the Full Age Spectrum Based on Serum Creatinine and Cystatin C in Predicting Mortality in Patients with Ischemic Stroke. Eur. J. Intern. Med. 2018;52:67–72. doi: 10.1016/j.ejim.2018.02.005. PubMed DOI

Demirkol S., Cakar M., Balta S., Unlu M., Kurt O., Akhan M. Serum Cystatin C Levels Should Correlate with Endothelial Dysfunction and Inflammation Indirectly Through Renal Function. Arq. Bras. Cardiol. 2013;100:303. doi: 10.5935/abc.20130070. PubMed DOI

Gelzo M., Giannattasio A., Maglione M., Muzzica S., D’Anna C., Scialò F., Gagliardo T., Grieco M., Tipo V., Castaldo G. Biomarkers of Endothelial Damage in Distinct Phases of Multisystem Inflammatory Syndrome in Children. Metabolites. 2022;12:680. doi: 10.3390/metabo12080680. PubMed DOI PMC

Chen D., Sun W., Li J., Wei B., Liu W., Wang X., Song F., Chen L., Yang J., Yu L. Serum Cystatin C and Coronavirus Disease 2019: A Potential Inflammatory Biomarker in Predicting Critical Illness and Mortality for Adult Patients. Mediat. Inflamm. 2020;2020:3764515. doi: 10.1155/2020/3764515. PubMed DOI PMC

Gupta A., Al-Tamimi A.O., Halwani R., Alsaidi H., Kannan M., Ahmad F. Lipocalin-2, S100A8/A9, and Cystatin C: Potential Predictive Biomarkers of Cardiovascular Complications in COVID-19. Exp. Biol. Med. 2022;247:1205–1213. doi: 10.1177/15353702221091990. PubMed DOI PMC

Salgado J.V., Souza F.L., Salgado B.J. How to Understand the Association between Cystatin C Levels and Cardiovascular Disease: Imbalance, Counterbalance, or Consequence? J. Cardiol. 2013;62:331–335. doi: 10.1016/j.jjcc.2013.05.015. PubMed DOI

Zhang T., Xu C., Zhao R., Cao Z. Diagnostic Value of SST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Front. Cardiovasc. Med. 2021;8:697837. doi: 10.3389/fcvm.2021.697837. PubMed DOI PMC

Masopustová A., Kreslová M., Sýkora J., Jehlička P., Trefil L., Kobr J. Endothelial dysfunction in Children and Young Adults: A combined Diagnostic Approach of Plethysmographic and Biochemical Markers. In: Duncan L.T., editor. Advances in Health and Disease. 1st ed. Volume 6. Nova Science Publishers; New York, NY, USA: 2018. pp. 189–202.

Kreslová M., Sýkorová A., Bittenglová R., Schwarz J., Pomahačová R., Jehlička P., Kobr J., Trefil L., Sýkora J. Age-Related Progression of Microvascular Dysfunction in Cystic Fibrosis: New Detection Ways and Clinical Outcomes. Physiol. Res. 2021;70:893–903. doi: 10.33549/physiolres.934743. PubMed DOI PMC

Kreslová M., Sýkorová A., Jehlička P., Kobr J., Sýkora J. Endothelial Dysfunction in Children and Young Adults: Clinical Implications and New Perspectives. In: Berhardt L.V., editor. Advances in Medicine and Biology. Volume 192. Nova Science Publishers; New York, NY, USA: 2022. pp. 99–195.

Trapani S., Rubino C., Lasagni D., Pegoraro F., Resti M., Simonini G., Indolfi G. Thromboembolic Complications in Children with COVID-19 and MIS-C: A Narrative Review. Front. Pediatr. 2022;10:944743. doi: 10.3389/fped.2022.944743. PubMed DOI PMC

Jone P.-N., John A., Oster M.E., Allen K., Tremoulet A.H., Saarel E.V., Lambert L.M., Miyamoto S.D., de Ferranti S.D. SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement from the American Heart Association. Circulation. 2022;145:e1037–e1052. doi: 10.1161/CIR.0000000000001064. PubMed DOI

Çiftel M., Ateş N., Yılmaz O. Investigation of Endothelial Dysfunction and Arterial Stiffness in Multisystem Inflammatory Syndrome in Children. Eur. J. Pediatr. 2021;181:91–97. doi: 10.1007/s00431-021-04136-6. PubMed DOI PMC